⌘K
Loading ticker…
Tilray Brands, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Tilray Brands, Inc. Common Stock (TLRY) has a 3-month relative strength percentile of 11 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 38. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.2%, relative volume 0.88×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
11 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
TLRY is in a stage 4 downtrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -17.0% / -48.2%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
TLRY appears in 1 ETF as of Mar 2026: SPDW at 0.00% weight, $300K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| SPDWState Street SPDR Portfolio Developed World ex-US ETF | 0.00% | $300K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TLRY Jan avg: -9.61% median: -18.91% win: 25% σ: 20.10% n: 4 2022-04-12 → 2026-05-29 | TLRY Feb avg: -10.66% median: -9.06% win: 25% σ: 14.90% n: 4 2022-04-12 → 2026-05-29 | TLRY Mar avg: 0.96% median: -10.57% win: 25% σ: 28.08% n: 4 2022-04-12 → 2026-05-29 | TLRY Apr avg: -11.74% median: -7.12% win: 0% σ: 11.59% n: 5 2022-04-12 → 2026-05-29 | TLRY May avg: -17.97% median: -12.25% win: 0% σ: 9.25% n: 5 2022-04-12 → 2026-05-29 | TLRY Jun avg: -11.88% median: -7.18% win: 0% σ: 12.61% n: 4 2022-04-12 → 2026-05-29 (current) | TLRY Jul avg: 35.41% median: 31.23% win: 100% σ: 20.42% n: 4 2022-04-12 → 2026-05-29 | TLRY Aug avg: 35.73% median: 10.55% win: 75% σ: 69.22% n: 4 2022-04-12 → 2026-05-29 | TLRY Sep avg: -4.65% median: -8.17% win: 50% σ: 23.80% n: 4 2022-04-12 → 2026-05-29 | TLRY Oct avg: -1.51% median: -14.68% win: 25% σ: 33.96% n: 4 2022-04-12 → 2026-05-29 | TLRY Nov avg: -15.50% median: -11.60% win: 25% σ: 17.75% n: 4 2022-04-12 → 2026-05-29 | TLRY Dec avg: 1.73% median: 5.16% win: 50% σ: 24.32% n: 4 2022-04-12 → 2026-05-29 |